Phase 3 study to assess the Efficacy and Safety of YYC405-T when added to Metformin and Dapagliflozin combination therapy in patients with type 2 diabetes mellitus who have inadequate glycemic control
Phase 3 study to assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients